Symbol="NRXP"
AssetType="Common Stock"
Name="NRX Pharmaceuticals Inc"
Description="NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware."
CIK="1719406"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23195200"
EBITDA="-38061000"
PERatio="None"
PEGRatio="None"
BookValue="-0.004"
DividendPerShare="0"
DividendYield="0"
EPS="-0.56"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.728"
ReturnOnEquityTTM="-2.378"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.56"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.555"
EVToRevenue="-"
EVToEBITDA="-0.613"
Beta="0.818"
num_52WeekHigh="1.54"
num_52WeekLow="0.302"
num_50DayMovingAverage="0.456"
num_200DayMovingAverage="0.813"
SharesOutstanding="70310000"
DividendDate="None"
ExDividendDate="None"
symbol="NRXP"
open="0.31"
high="0.33"
low="0.30"
price="0.33"
volume="197203.00"
latest_trading_day="2023-08-11"
previous_close="0.31"
change="0.02"
change_percent="6.4194%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="321171"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="520"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0085.jpeg"
image_negative_thumbnail_id_2="158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="976"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_positive_thumbnail_id_2="603"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
